Who
Dorothy E. Puhy
Director
Company insider
Files Form 4 as: Director, MiMedx Group; Director, Azenta; Director, Abiomed; Director, Mirror Merger Sub 2; Director, Reebok International.
In numbers
- Trades disclosed
- 311
- Buys
- 0
- Sells
- 28
- Bought
- $0
- Sold
- $22.0M
- Companies
- 5
- Companies where not an officer
- 5
- First trade
- 30 Dec 2005
- Last trade
- 10 Jun 2026
- Last filed
- 12 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Jun 2026filed 12 Jun 2026 | MDXG MiMedx GroupMedical Devices | SEC FORM 4 Code A | $185K50,913 at $3.64 | filing |
| 10 Jun 2026filed 12 Jun 2026 | MDXG MiMedx GroupMedical Devices | SEC FORM 4 Code A | $185K50,913 at $3.64 | filing |
| 18 Jun 2025filed 23 Jun 2025 | MDXG MiMedx GroupMedical Devices | SEC FORM 4 Code A | $185K28,609 at $6.47 | filing |
| 5 Jun 2024filed 6 Jun 2024 | MDXG MiMedx GroupMedical Devices | SEC FORM 4 Code A | $210K28,988 at $7.26 | filing |
| 13 Feb 2023filed 15 Feb 2023 | AZTA AzentaSemiconductor Equipment | SEC FORM 4 Code A | —3,604 at $0.00 | filing |
| 22 Dec 2022filed 27 Dec 2022 | Abiomed | SEC FORM 4 Code D | —3,255 at $0.00 | filing |
| 22 Dec 2022filed 27 Dec 2022 | Abiomed | SEC FORM 4 Code D | —11,335 at $0.00 | filing |
| 11 Aug 2022filed 12 Aug 2022 | Abiomed | SEC FORM 4 Code F | $77K263 at $293.34 | filing |
| 10 Aug 2022filed 12 Aug 2022 | Abiomed | SEC FORM 4 Code A | —681 at $0.00 | filing |
| 12 Aug 2021filed 13 Aug 2021 | Abiomed | SEC FORM 4 Code F | $89K279 at $319.88 | filing |
| 11 Aug 2021filed 13 Aug 2021 | Abiomed | SEC FORM 4 Code A | —625 at $0.00 | filing |
| 1 Mar 2021filed 3 Mar 2021 | Mirror Merger Sub 2option or derivative | SEC FORM 4 Code D | $684K9,372 at $73.00 | filing |
| 1 Mar 2021filed 3 Mar 2021 | Mirror Merger Sub 2option or derivative | SEC FORM 4 Code D | $254K5,680 at $44.77 | filing |
| 1 Mar 2021filed 3 Mar 2021 | Mirror Merger Sub 2option or derivative | SEC FORM 4 Code D | $270K7,451 at $36.24 | filing |
| 1 Mar 2021filed 3 Mar 2021 | Mirror Merger Sub 2option or derivative | SEC FORM 4 Code D | $208K5,737 at $36.29 | filing |
| 1 Mar 2021filed 3 Mar 2021 | Mirror Merger Sub 2option or derivative | SEC FORM 4 Code D | $237K3,252 at $73.00 | filing |
| 1 Mar 2021filed 3 Mar 2021 | Mirror Merger Sub 2 | SEC FORM 4 Code D | —23,981 at $0.00 | filing |
| 12 Feb 2021filed 16 Feb 2021 | Eaton Vanceoption or derivative | SEC FORM 4 Code A | —50 at $0.00 | filing |
| 12 Feb 2021filed 16 Feb 2021 | Eaton Vanceoption or derivative | SEC FORM 4 Code A | —17 at $0.00 | filing |
| 1 Feb 2021filed 3 Feb 2021 | Abiomed | SEC FORM 4 Sold | $638K1,846 at $345.64 | filing |
News
No headline names them, or the companies they trade most, lately.